HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Hébert, P. C. Articles by Marshall, J. Search for Related Content PubMed PubMed Citation Articles by Hébert, P. C. Articles by Marshall, J.

The Design of Randomized Clinical Trials in Critically Ill Patients^*

^* From the Critical Care Program (Dr. Hébert), University of Ottawa, Ottawa; University of Toronto (Dr. Marshall), Toronto; Clinical Epidemiology Unit (Dr. Wells), University of Ottawa, Ottawa; and Department of Epidemiology and Biostatistics, McMaster University (Dr. Cook), Hamilton, ON, Canada.

Correspondence to: Paul C. Hébert, MD, MHSc(Epid), Ottawa Health Research Institute, The Ottawa Hospital/General Campus, 501 Smyth Rd, Room 1812H, Box 201, Ottawa, ON, K1H 8 L6 Canada

There are a number of difficulties in the conduct of randomized trials in the critically ill. These include difficulties in the definition of diseases and syndromes, a heterogenous population of patients undergoing a variety of therapeutic interventions, and outcomes that may not be able to discriminate between beneficial and risky therapies. Following a brief description of different randomized clinical trials (RCTs) and design philosophies, we outline the effects of different design choices in the complex critical care environment. Once the study topic has been determined to be relevant and important, then the potential investigator must establish whether efficacy or effectiveness will be the focus of the RCT. If an effectiveness design philosophy is chosen, then broad representation of study sites, liberal eligibility criteria, easily implemented intervention study protocols, and patient-centered outcomes should be chosen. The potential investigator wishing to establish efficacy will conduct the study in the centers of excellence and adopt stringent eligibility criteria, rigorous study protocols, and opt for outcomes that will be sensitive to change. In conclusion, we describe some of the major challenges and possible solutions to help a potential investigator through the myriad of difficulties in initiating an RCT in a complex environment.

Key Words: critical care • methodology • randomized trials • study protocols

This article has been cited by other articles:

				H Mann Controversial choice of a control intervention in a trial of ventilator therapy in ARDS: standard of care arguments in a randomised controlled trial J. Med. Ethics, September 1, 2005; 31(9): 548 - 553. [Abstract] [Full Text] [PDF]

				D. Cook Is Albumin Safe? N. Engl. J. Med., May 27, 2004; 350(22): 2294 - 2296. [Full Text] [PDF]

				K. D. Chinsky Ventilator-Associated Pneumonia: Is There Any Gold in These Standards? Chest, December 1, 2002; 122(6): 1883 - 1885. [Full Text] [PDF]